Clinical Trial of Iclepertin Effect on Cognition and Functional Capacity in Schizophrenia (CONNEX-1)
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Schizophrenia
Related studies linked through entity extraction aliases.
A Single Ascending Dose Study Of CY150112 After Single Oral Administration in Healthy Chinese Subjects
- Status
- UNKNOWN
- Phase
- PHASE1
A Clinical Trial to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic People With Schizophrenia, Followed by an Open-label Extension Phase
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Safety, Biomarker Study of RL-007 in Subjects With Schizophrenia
- Status
- COMPLETED
- Phase
- PHASE2
The Effect of Psychoeducation Based on Uncertainty In Illness Theory On Schizophrenia Caregivers
- Status
- COMPLETED
- Phase
- NA
An Open-label Study to Assess the Long-term Safety, Tolerability, and Efficacy of KarXT in Adult Patients With Schizophrenia (EMERGENT-5)
- Status
- COMPLETED
- Phase
- PHASE3
Medial-prefrontal Enhancement During Schizophrenia Systems Imaging
- Status
- RECRUITING
- Phase
- NA
fMRI-based Neurofeedback to Relieve Drug-resistant Auditory Hallucinations
- Status
- RECRUITING
- Phase
- NA
PET Trial to Evaluate Target Occupancy of CVL-231 on Brain Receptors Following Oral Dosing
- Status
- COMPLETED
- Phase
- PHASE1
Effects of Auditory Stimulation on Sleep and Memory in Schizophrenia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Effect of Individual Cognitive Stimulation at Home in Adults With Psychotic Disorders
- Status
- COMPLETED
- Phase
- NA
Study of the Effectiveness of Mental Contrasting and Implementation Intention in the Management of Apathy in Schizophrenia
- Status
- UNKNOWN
- Phase
- NA
Safety, Tolerability, and Pharmacokinetics of Lumateperone in Pediatric Patients With Schizophrenia or Schizoaffective Disorder
- Status
- COMPLETED
- Phase
- PHASE1
The Outcomes Among Persons With Schizophrenia Under the Peer-support Service in Vocational Rehabilitation Program
- Status
- COMPLETED
- Phase
- NA
Vildagliptin for Treatment of Antipsychotic-induced Dyslipidemia
- Status
- WITHDRAWN
- Phase
- PHASE2
Virtual Cognitive Behavioural Therapy for Psychosis
- Status
- COMPLETED
- Phase
- NA
Monotherapy of an NMDA Enhancer for Schizophrenia
- Status
- RECRUITING
- Phase
- PHASE2
A 12-Month Observational Prospective Cohort Study to Analyze Cardiometabolic Profile Changes to Switch to Lurasidone in Patients With Schizophrenia. RESPECT Study.
- Status
- TERMINATED
- Phase
- N/A
Salutogenic Approach Based Interview With People With Schizophrenia
- Status
- COMPLETED
- Phase
- NA
A Study to Assess Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Adult Patients With Schizophrenia (EMERGENT-3)
- Status
- COMPLETED
- Phase
- PHASE3